Schedule I Fans Review Bombing IP Infringement Issuer's Game

Fans of the hit drug dealer game Schedule I are rushing to use their weapon, i.e., Steam review rights, to protect the solo developer Tyler. They're now review-bombing the 2020 crime simulation game Drug Dealer Simulator and its sequel, whose publisher recently started an investigation into the creator of Schedule I for potential IP infringement and unfair competition. 

The publisher has been deemed "greedy and jealous," as apparently, the new game by one developer went viral and was received better than their game. Some question their decision to hire lawyers against an individual capable of achieving better results in the same game genre instead of spending time working on improving games. 

Nearly 2,300 negative reviews were submitted to Drug Dealer Simulator and its sequel since April 3, when Movie Games S.A.'s announcement was released, making both games' 30-day reviews overwhelmingly negative with a rating of 17%.

If you think the 17% are gamers who enjoy the game, you might be wrong. Thinking the possibility of potential buyers only checking out positive reviews, some supporters also upvote Drug Dealer Simulator while blatantly recommending Schedule I in their comments. "boring, repetitive, unoptimized, play schedule 1 <3," one player, giving the game a recommend review, writes. As a result, the actual negative percentage is much higher.

On the other side, in just one day, nearly 8,000 more players have praised Schedule I. The game remains at 98% positive on Steam, with almost 78,000 comments, compared to nearly 70,000 reviewers yesterday.

"First time I buy a game and feel like I'm the one who robbed the devs," player wiNter said. "Game is literally the peak of what we've wanted from a drug dealing game and it's Early Access!" wrote losangelesi.